Financial Data and Key Metrics Changes - Overall sales for Q4 2025 reached $947 million, a 15% increase year-over-year, driven by 11% organic growth and contributions from the INC Solutions acquisition [4][5] - Operating income increased by 14%, with an operating margin of 19.7% [5][6] - Diluted earnings per share grew by 16% year-over-year, primarily due to higher A&D sales [5][6] - Free cash flow was strong at $315 million, up 13%, reflecting a 224% conversion rate [6] - For the full year 2025, diluted earnings per share increased by 21%, and adjusted free cash flow reached a record $554 million [7][8] Business Line Data and Key Metrics Changes - Aerospace and Defense (A&D) markets saw a 16% growth, with commercial aerospace sales increasing over 20% [5][6] - The defense electronics segment experienced a 17% sales growth, driven by increased demand for tactical communications equipment [12][14] - The naval and power segment's sales increased by 21%, supported by strong revenue growth in naval defense and aftermarket revenues [15][16] Market Data and Key Metrics Changes - The overall order book reached a record $4.1 billion, up 10% year-over-year, with a book-to-bill ratio of nearly 1.2 times [8][10] - New orders in Q4 increased by 18%, reflecting solid demand in naval defense and commercial nuclear markets [6][10] - Commercial nuclear sales showed tremendous growth, driven by strong demand for aftermarket equipment and advancements in SMR designs [9][21] Company Strategy and Development Direction - The company continues to execute its "Pivot to Growth" strategy, focusing on operational and commercial excellence to drive sales and profitability [4][10] - Investments in research and development are being accelerated to support future organic growth, with a commitment to grow R&D faster than sales over time [7][10] - The company is positioned to benefit from increased global defense spending and the U.S. government's focus on nuclear energy dominance [32][36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the future, projecting organic sales growth of 6%-8% for 2026, with operating income growth expected to outpace sales growth [10][11] - The company anticipates another year of record free cash flow generation, with a target of $575 million-$595 million for 2026 [29][30] - Management acknowledged challenges in the defense market due to timing delays but remains optimistic about long-term growth opportunities [8][10] Other Important Information - The company executed a record $465 million in share repurchases in 2025 and increased its annual dividend for the ninth consecutive year [10] - Capital expenditures are projected to increase by more than 25% year-over-year, reflecting ongoing investments to support growth [29][30] Q&A Session Summary Question: Exposure to missile programs and growth opportunities - Management indicated that while there is some exposure to missile telemetry and flight test instrumentation, the primary focus remains on broader defense capabilities aligned with U.S. military priorities [43][44] Question: Clarification on expected AP1000 orders - Management stated that the first orders could come from either European customers or the U.S., with ongoing discussions with Westinghouse regarding production ramp scenarios [46][47] Question: Free cash flow guidance and working capital dynamics - Management highlighted improvements in working capital management, with a target of approximately 18% working capital as a percentage of sales for 2026 [55][57] Question: C-17 order timing and defense electronics bookings - Management confirmed that the C-17 order was booked in Q1, and noted that delayed bookings in defense electronics were due to various timing issues [60][61] Question: Operational and commercial excellence initiatives - Management emphasized that operational excellence remains a core focus, with ongoing initiatives expected to contribute positively to margins in 2026 [68][72]

Financial Data and Key Metrics Changes - Sales for Q4 2025 reached $947 million, a 15% increase year-over-year, driven by 11% organic growth and contributions from the INC Solutions acquisition [4][5] - Operating income increased by 14%, with an operating margin of 19.7% [5][6] - Diluted earnings per share grew by 16% year-over-year, primarily due to higher A&D sales [5][6] - Free cash flow was strong at $315 million, up 13%, reflecting a 224% conversion rate [5][6] - For the full year 2025, operating margin expanded by 110 basis points to a record 18.6% [6][7] - Diluted earnings per share for the full year increased by 21% year-over-year [7] Business Line Data and Key Metrics Changes - Aerospace and Defense (A&D) markets saw a 16% growth, driven by ground and naval defense revenues [5][6] - Commercial aerospace sales increased by over 20% [5] - The defense electronics segment experienced a 17% sales growth, with increased demand for tactical communications equipment [12][13] - Naval and power segment sales increased by 21%, driven by strong revenue growth in naval defense [14][15] Market Data and Key Metrics Changes - The overall order book reached a record of $4.1 billion, up 10% year-over-year, with a book-to-bill ratio of nearly 1.2 times [8][10] - New orders in Q4 increased by 18%, reflecting solid demand in naval defense and commercial nuclear markets [6][10] - Commercial nuclear market growth was driven by strong demand for aftermarket equipment and advancements in small modular reactor (SMR) designs [9][19] Company Strategy and Development Direction - The company continues to execute its "Pivot to Growth" strategy, focusing on operational and commercial excellence [4][6] - Investments in research and development are being accelerated to support future organic growth [7][10] - The company is committed to capital allocation towards high-return opportunities to enhance shareholder value [10][30] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth in defense spending, particularly with a record U.S. budget and increased NATO commitments [30][34] - The company anticipates organic sales growth of 6%-8% for 2026, with operating income growth expected to outpace sales growth [11][21] - Management noted potential challenges in ground defense due to timing delays but remains confident in the overall defense market [8][80] Other Important Information - The company executed a record $465 million in share repurchases in 2025 and increased its annual dividend for the ninth consecutive year [10][11] - Capital expenditures are projected to increase by more than 25% year-over-year, reflecting ongoing investments to support growth [26] Q&A Session Summary Question: Can you provide more color regarding your exposure to missile programs? - The company has minor content related to missiles, primarily in telemetry and flight test instrumentation, but is well-positioned in broader defense areas related to the Golden Dome initiative [41][43] Question: What is the expected order for AP1000 reactors in 2026? - Orders could come from either European customers or the U.S., with Westinghouse as the primary customer. The size of the first order is not yet determined [45][46] Question: Can you elaborate on the dynamics enabling strong free cash flow despite increased CapEx? - The company has improved working capital management, with a target of approximately 18% working capital as a percentage of sales, which is expected to be a record [54][56] Question: What are the headwinds in the aerospace and industrial segments? - The company anticipates continued growth in naval defense and commercial nuclear, with some challenges in margin due to the transition to prototype work in SMRs [62][63] Question: How will operational and commercial excellence initiatives contribute moving forward? - The company expects continued benefits from operational excellence initiatives, with a projected incremental contribution margin on sales of roughly 25% [67][71]

Financial Data and Key Metrics Changes - Revenues increased by 5% to $1.7 billion, EBITDA grew by 12% to $5.3 billion, EPS rose by 19% to $2.93, and free cash flow was up 16% to $2.4 billion [7][28][30] - Net debt to EBITDA ratio improved to 2.5 times, with a target of 2 times by 2027 [8][28] Business Line Data and Key Metrics Changes - Innovative portfolio showed strong growth: AUSTEDO grew by 34% to $2.26 billion, UZEDY increased by 63% to $191 million, and AJOVY rose by 30% to $673 million [9][10][12] - Generics business remained flat, with U.S. growth at 2%, international markets at 1%, and Europe declining by 2% [16][30] Market Data and Key Metrics Changes - The U.S. generics market faced challenges, particularly with the loss of revenue from generic Revlimid, expected to impact 2026 [34][37] - The biosimilars portfolio is expanding, with 10 assets currently in the market and plans to launch 6 additional by 2027 [18][30] Company Strategy and Development Direction - The company is focused on its "Pivot to Growth" strategy, emphasizing innovative products and a shift from generics to biopharma [4][28] - A target of $700 million in net savings by 2027 is set, with $70 million achieved in 2025 [29][33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving long-term financial targets for 2030, with a focus on innovative growth and margin expansion [28][41] - The company anticipates a gradual revenue increase in 2026, despite challenges in the generics segment [34][39] Other Important Information - The company received a $500 million milestone payment from Sanofi, positively impacting revenue and free cash flow [30] - Non-GAAP gross margin increased to 56.2%, with expectations for 54.5%-55.5% in 2026 [31][35] Q&A Session Summary Question: Insights on AUSTEDO and UZEDY pricing dynamics - Management highlighted strong TRX growth for AUSTEDO and maintained a disciplined approach to pricing, expecting continued growth despite competitive pressures [50][51] - For UZEDY, management acknowledged the mix of Medicaid and Medicare affecting profitability but remained optimistic about continued momentum [53][54] Question: Pipeline excitement versus market perception - Management noted that the rapid development of the pipeline may have surprised investors, emphasizing the quality and potential of new products [57][60] Question: Funding R&D and economic implications of partnerships - Management stated that partnerships do not significantly impact economics, as new product launches enhance gross margins and EBITDA [65][66] Question: Expectations for TL1A maintenance data - Management expressed optimism about the upcoming maintenance data, citing the potency and selectivity of the product [70][71]

Financial Data and Key Metrics Changes - Sales for the second quarter of 2025 reached $877 million, a 12% year-over-year increase, driven by strong organic growth of 9% [6][9] - Operating income increased by 20% year-over-year, resulting in a 130 basis points expansion in overall operating margin [7][16] - Diluted earnings per share rose by 21% year-over-year, slightly exceeding expectations [8] - Free cash flow was $117 million, reflecting a 17% year-over-year improvement and nearly 100% cash conversion [8][10] - The company raised its full-year sales growth guidance to 9% to 10% and expects diluted EPS growth of 16% to 19% [10][25] Business Line Data and Key Metrics Changes - Aerospace and Industrial segment sales increased by 3%, with solid OEM sales growth in commercial aerospace [11] - Defense Electronics segment sales grew by 11%, driven by increased sales of embedded computing equipment [12] - Naval and Power segment sales surged by 19%, primarily due to higher naval defense revenues [15] Market Data and Key Metrics Changes - The overall book-to-bill ratio across Aerospace and Defense markets was 1.2 times, indicating strong demand [8] - The backlog increased by 12% year-to-date, reaching a record of over $3.8 billion [9] - Direct foreign military sales are expected to grow by approximately 20% in 2025, reflecting increased demand from NATO and allied countries [19][31] Company Strategy and Development Direction - The company is focused on a "pivot to growth" strategy, emphasizing operational excellence and collaboration on R&D projects [5][39] - Key growth areas identified include defense and commercial nuclear sectors, with expectations for significant long-term opportunities [28][34] - The company plans to leverage advancements in AI and machine learning to enhance its defense applications [31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving strong financial performance in 2025, supported by a robust order book and operational growth [5][39] - The company anticipates continued growth in defense spending, particularly in the U.S. and among NATO allies [28][31] - Management highlighted the importance of maintaining a disciplined capital allocation strategy while pursuing growth opportunities [39] Other Important Information - The Board approved a $400 million increase in share repurchase authorization and a 14% increase in the quarterly dividend [9] - The company expects to generate free cash flow exceeding $520 million to $535 million, reflecting an improved conversion rate of approximately 108% [26] Q&A Session Summary Question: What is driving the growth acceleration in commercial aerospace? - Management noted a conservative position on commercial aerospace initially, but positive signals from customers indicate strong growth potential despite industry challenges [42][44] Question: Can you elaborate on the applications of the new GPU chips? - The new GPU chips are being utilized for tactical edge applications, enhancing decision-making capabilities in defense systems [47][48] Question: How sustainable is the margin performance in Defense Electronics? - Management indicated ongoing restructuring and operational excellence initiatives are driving margin improvements, with further opportunities for expansion [53][55] Question: What is the outlook for the M&A pipeline? - The company is actively exploring M&A opportunities but remains disciplined in its approach, prioritizing strategic fits [67][69] Question: How do you expect to grow direct foreign military sales? - Management highlighted strong positions in defense electronics and partnerships with NATO allies as key growth drivers for direct foreign military sales [90][92]